LPL Financial LLC Reduces Position in Option Care Health, Inc. (NASDAQ:OPCH)

LPL Financial LLC reduced its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 59.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,638 shares of the company's stock after selling 15,544 shares during the quarter. LPL Financial LLC's holdings in Option Care Health were worth $247,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. raised its stake in shares of Option Care Health by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after buying an additional 147,054 shares during the period. Magnetar Financial LLC lifted its holdings in Option Care Health by 23.1% during the fourth quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company's stock valued at $54,534,000 after purchasing an additional 441,265 shares during the last quarter. Victory Capital Management Inc. boosted its position in Option Care Health by 31.1% during the fourth quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock worth $49,310,000 after purchasing an additional 503,840 shares during the period. Villere ST Denis J & Co. LLC raised its position in shares of Option Care Health by 18.5% in the fourth quarter. Villere ST Denis J & Co. LLC now owns 1,344,608 shares of the company's stock valued at $31,195,000 after purchasing an additional 209,502 shares during the period. Finally, American Century Companies Inc. raised its position in shares of Option Care Health by 10.9% in the fourth quarter. American Century Companies Inc. now owns 1,273,523 shares of the company's stock valued at $29,546,000 after purchasing an additional 125,107 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Price Performance

Shares of NASDAQ:OPCH traded up $0.78 during trading on Friday, reaching $32.95. The company had a trading volume of 3,358,100 shares, compared to its average volume of 1,827,653. The company has a fifty day moving average of $33.35 and a two-hundred day moving average of $28.85. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $5.41 billion, a P/E ratio of 27.69, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. During the same quarter in the prior year, the firm earned $0.26 earnings per share. The firm's revenue was up 16.3% on a year-over-year basis. Equities research analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have issued reports on OPCH. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $38.00 to $40.00 in a report on Wednesday. JMP Securities reiterated a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a research report on Tuesday, April 22nd. JPMorgan Chase & Co. raised their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Finally, Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a report on Wednesday. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.